Justine studied biological sciences at the University of Warwick before diving straight into a PhD at the same institution, working on how HIV hijacks certain transport pathways in cells. After subsequently working as a science writer for several years, Justine joined the Science Communications team at Cancer Research UK in 2016, helping communicate research on cancer to the public and media.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
This week’s cancer news features calorie crackdown plans for childhood obesity, vaping in teens and vitamin C for blood cancers. Read our digest for more.
In part 2 of our new radiotherapy series, we discuss proton beam therapy. What can and can’t it offer? And what does its arrival in the UK mean for patients?
Today we’re launching a brand new series on radiotherapy. In this instalment, find out about the treatment’s fascinating history and how it works.
In our new #ScienceSurgery series, we’re answering your cancer science questions. Read our answer to Victoria’s question.
Find out how an unexpected discovery by our scientists almost 2 decades ago is helping improve cancer diagnosis today.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.